AWS has launched Amazon Bio Discovery, an AI application aimed at speeding early-stage drug research. Amazon says Memorial Sloan Kettering used the system to compress an antibody design process from a year into weeks, an early signal that AI drug discovery is moving from pitch decks to workflow.